We would like to thank our Lymphoma Canada Scientific Advisory Board for their continued commitment to the lymphoma community. Their collaboration helps to further Lymphoma Canada’s mission of empowering patients and caregivers through education, support, advocacy, and research.

Please view this special letter of thanks

Dr. John Kuruvilla, CHAIR; MD, FRCPC – Hematologist in the Division of Medical Oncology and Hematology, Princess Margaret Hospital

Dr. David MacDonald, MD, FRCPC – Hematologist, The Ottawa Hospital

Dr. Graeme Fraser, MD, FRCPC – Associate Professor, Department of Oncology – Division of Malignant Hematology, McMaster University

Dr. Doug Stewart, MD, FRCPC – Professor in the departments of Medicine and Oncology, Divisions of Medical Oncology, Hematology, and Hematological Malignancies, University of Calgary

Dr. Tony Reiman, MD, SM, FRCPC – Medical Oncologist at Canadian Cancer Society Research, Chair at University of New Brunswick, and Assistant Dean, Research at Dalhousie Medicine New Brunswick

Dr. Kerry Savage, MD – Medical Oncologist at the BC Cancer Agency, Associate Professor at the University of British Columbia

Dr. David Hodgson, MD, MPH, FRCPC – Associate Professor, Department of Radiation Oncology, University of Toronto Staff Radiation Oncologist, Princess Margaret Hospital/University Health Network

Dr. Jean-Francois Larouche  – Hémato-oncologue chez Centre hospitalier affilié universitaire de Québec

Dr. Mark Bosch – Director of Hematology at the Saskatchewan Cancer Agency

Dr. Joanne Hickey – Associate Professor of Medicine (Hematology), Memorial University

Dr. Pamela Skrabek – Chair Lymphoproliferative Disease Site Group Hematologist at CancerCare Manitoba

Lymphoma Canada could not do what we do without the support of these exceptional professionals from the medical community and would like to thank the following people for their past service to our Scientific Advisory Board:

Dr. Joe Connors, CM, PAST CHAIR; MD Clinical Professor, University of British Columbia; Chair, Lymphoma Tumour Group, British Columbia Cancer Agency

Dr. Isabelle Bence-Bruckler, MD, FRCPC; Hematologist, Associate Professor of Medicine, Member, Blood and Marrow Transplant Program, Ottawa General Hospital

Dr. Spencer Gibson, PhD, Associate Professor, Manitoba Institute of Cell Biology, Department of Biochemistry and Medical Genetic, University of Manitoba

Dr. Mary Gospodarowicz, MD, FRCPC FRCR(Hon) Professor and Chair, Department of Radiation Oncology, University of Toronto, Chief, Radiation Medicine Program, Princess Margaret Hospital

Dr. Kevin Imrie, MD, FRCPC – Physician-in-Chief, Sunnybrook Health Sciences Centre, Vice-Chair, Education, Department of Medicine, University of Toronto, Professor of Medicine, University of Toronto

Dr. Ralph M. Meyer, MD, FRCP(C), Director of the National Cancer Institute of Canada (NCIC) Clinical Trials Group and Holder of the Edith Eisenhauer Chair in Clinical Cancer Research at Queen’s University

Dr. Diponkar Banerjee, MBChB, PhD, FRCPC, Clinical Professor, Department of Laboratory Medicine and Pathology, University of British Columbia; Director, Department of Pathology and Laboratory Medicine, Vancouver Cancer Centre; Provincial Program Leader, Cancer Pathology Program, BC Cancer

Dr. Brent W. Zanke, Vice-President OICR and Director, Ontario Tumour Bank